Randomized phase II study of capecitabine plus cisplatin with or without sorafenib in patients with metastatic gastric cancer ( STARGATE )

Author:

Ryu Min‐Hee1ORCID,Lee Kyung Hee2,Shen Lin3ORCID,Yeh Kun‐Huei4,Yoo Changhoon1,Hong Young Seon5,Park Young Iee6,Yang Sung Hyun7,Shin Dong Bok8,Zang Dae Young9,Kang Won Ki10,Chung Ik‐Joo11,Kim Yeul Hong12ORCID,Ryoo Baek‐Yeol1,Nam Byung‐Ho13,Park Young Soo14,Kang Yoon‐Koo1

Affiliation:

1. Department of Oncology, Asan Medical Center University of Ulsan College of Medicine Seoul South Korea

2. Department of Hemato‐oncology Yeungnam University Hospital Daegu South Korea

3. Department of Gastrointestinal Medical Oncology Peking University School of Oncology, Beijing Cancer Hospital and Institute Beijing China

4. Department of Oncology National Taiwan University Hospital; and Graduate Institute of Oncology, National Taiwan University College of Medicine Taipei Taiwan

5. Division of Medical Oncology, Department of Internal Medicine, Seoul St. Mary's Hospital The Catholic University of Korea College of Medicine Seoul South Korea

6. Center for Gastric Cancer Research Institute and Hospital, National Cancer Center Goyang Gyeonggi South Korea

7. Department of Internal Medicine, Korea Cancer Center Hospital Seoul South Korea

8. Division of Hematology/Oncology, Department of Internal Medicine Gachon University Gil Hospital Incheon South Korea

9. Division of Hematology‐Oncology, Department of Internal Medicine Hallym University Medical Center, Hallym University College of Medicine Anyang South Korea

10. Division of Hematology‐Oncology, Department of Medicine, Samsung Medical Center Sungkyunkwan University School Medicine Seoul South Korea

11. Department of Hematology‐Oncology Chonnam National University Hwasun Hospital Gwangju South Korea

12. Division of Hemato‐Oncology, College of Medicine Korea University, Anam Hospital Seoul South Korea

13. Biometric Research Branch, National Cancer Center Goyang Gyeonggi South Korea

14. Department of Pathology, Asan Medical Center University of Ulsan College of Medicine Seoul South Korea

Funder

Bayer

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3